Cargando...
Oncologists’ Barriers and Facilitators for Oncotype DX Use: Qualitative Study
BACKGROUND: Oncotype DX (ODX), a tumor gene profiling test, has been incorporated into clinical guidelines to aid in adjuvant chemotherapy decision-making for early-stage, hormone receptor positive breast cancer patients. Despite US guidelines, less than half of eligible women receive testing. Reaso...
Guardado en:
| Publicado en: | Int J Technol Assess Health Care |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6526532/ https://ncbi.nlm.nih.gov/pubmed/27958190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S026646231600060X |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|